Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Langdon

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Neurology|January 28, 1999
Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?J A Freeman, D W Langdon, J C Hobart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2000
Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosisJ A Freeman, J C Hobart, D W Langdon, et al.
Cognitive Neuropsychiatry|February 1, 1996
Resolution of left hemisphere cognitive dysfunction in multiple sclerosis with magnetic resonance correlates: a case reportL Rozewicz, D W Langdon, C A Davie, et al.
European Neurology|May 3, 2013
Reports of patients and relatives from the CogniCIS study about cognition in clinically isolated syndrome: what are our patients telling us?D W Langdon, R H B Benedict, E M Wicklein, et al.
Molecular Biology of the Cell|October 12, 2000
Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversionT M Fournier, L Lamorte, C R Maroun, et al.
Behavioural Neurology|August 18, 2010
Cerebellar information processing in relapsing-remitting multiple sclerosis (RRMS)E Lesage, M A J Apps, A L Hayter, et al.
European Journal of Neurology|August 25, 2021
Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosisDawn W Langdon, Davorka Tomic, Iris-Katharina Penner, et al.
Neurology|August 29, 2001
Evidence-based measurement: which disability scale for neurologic rehabilitation?J C Hobart, D L Lamping, J A Freeman, et al.
Multiple Sclerosis and Related Disorders|November 23, 2015
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of lifeDániel Sandi, Tibor Rudisch, Judit Füvesi, et al.
Journal of the Neurological Sciences|October 12, 2018
Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE studyC Bakirtzis, E Konstantinopoulou, D W Langdon, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Neurology|January 28, 1999
Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?J A Freeman, D W Langdon, J C Hobart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2000
Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosisJ A Freeman, J C Hobart, D W Langdon, et al.
Cognitive Neuropsychiatry|February 1, 1996
Resolution of left hemisphere cognitive dysfunction in multiple sclerosis with magnetic resonance correlates: a case reportL Rozewicz, D W Langdon, C A Davie, et al.
European Neurology|May 3, 2013
Reports of patients and relatives from the CogniCIS study about cognition in clinically isolated syndrome: what are our patients telling us?D W Langdon, R H B Benedict, E M Wicklein, et al.
Molecular Biology of the Cell|October 12, 2000
Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversionT M Fournier, L Lamorte, C R Maroun, et al.
Behavioural Neurology|August 18, 2010
Cerebellar information processing in relapsing-remitting multiple sclerosis (RRMS)E Lesage, M A J Apps, A L Hayter, et al.
European Journal of Neurology|August 25, 2021
Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosisDawn W Langdon, Davorka Tomic, Iris-Katharina Penner, et al.
Neurology|August 29, 2001
Evidence-based measurement: which disability scale for neurologic rehabilitation?J C Hobart, D L Lamping, J A Freeman, et al.
Multiple Sclerosis and Related Disorders|November 23, 2015
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of lifeDániel Sandi, Tibor Rudisch, Judit Füvesi, et al.
Journal of the Neurological Sciences|October 12, 2018
Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE studyC Bakirtzis, E Konstantinopoulou, D W Langdon, et al.
Pageof 8